In The News

Life Sciences Attorney Highlights Implications of Pharma Regulatory Changes in China

Practices: China Life Sciences, Health Care

Ropes & Gray chief China life sciences advisor Katherine Wang discussed new and proposed regulatory drug rule changes in China in an article featured in the March 2014 issue of Scrip Regulatory Affairs.

Click here read the article.

Cookie Settings